Ribavirin has been studied for over 20 years as a potential therapy against a number of RNA and DNA viruses. It is well known that Ribavirin in combination with Interferon is a key antiviral component in the treatment of Hepatitis C virus infection. In this book, the authors discuss the biochemistry, clinical applications and potential side effects of Ribavirin. Topics include optimising Ribavirin use for the treatment of Hepatitis C; Ribavirin and its great potential in infectious diseases; the antiviral actions of Ribavirin; a novel prediction method for the responsiveness of Hepatitis C patients to drug treatment; and Ribavirins intolerable cough during HCV combination therapy which can be overcome by replacement with Nitazoxanide.
Preface; Optimizing Ribavirin Use for the Treatment of Hepatitis C; Ribavirin & its Great Potentials in Infectious Diseases; Antiviral Actions of Ribavirin; A Novel Prediction Method for the Responsiveness of Hepatitis C Patients to Drug Treatment; Ribavirin Intolerable Cough During HCV Combination Therapy Can Be Overcome by Nitazoxanide Replacement; Index.
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.